financetom
Business
financetom
/
Business
/
Cigna Insider Sold Shares Worth $338,080, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Cigna Insider Sold Shares Worth $338,080, According to a Recent SEC Filing
Jun 13, 2024 2:49 PM

05:41 PM EDT, 06/13/2024 (MT Newswires) -- Elder Granger, Director, on June 12, 2024, sold 1,000 shares in Cigna ( CI ) for $338,080. Following the Form 4 filing with the SEC, Granger has control over a total of 5,471 shares of the company, with 5,471 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1739940/000122520824006818/xslF345X03/doc4.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Amazon.com's Price Controls on Marketplace Raise Concern From German Antitrust Watchdog
Amazon.com's Price Controls on Marketplace Raise Concern From German Antitrust Watchdog
Jun 2, 2025
09:20 AM EDT, 06/02/2025 (MT Newswires) -- Amazon.com's ( AMZN ) price controls for retailers on its marketplace may be considered abuse under German and European Union laws, Germany's Federal Cartel Office said Monday. Citing its preliminary legal assessment, the German antitrust watchdog said that if Amazon's ( AMZN ) price control mechanisms determine that seller prices are too high,...
Kymera Therapeutics Says KT-621 Well Tolerated in Phase 1 Trial, Showing Potential to Treat Th2 Diseases
Kymera Therapeutics Says KT-621 Well Tolerated in Phase 1 Trial, Showing Potential to Treat Th2 Diseases
Jun 2, 2025
09:18 AM EDT, 06/02/2025 (MT Newswires) -- Kymera Therapeutics ( KYMR ) said Monday that the results from its phase 1 study of KT-621 showed complete STAT6 degradation in both blood and skin, demonstrating a potential to treat Th2 diseases such as atopic dermatitis. The drug was well tolerated with a safety profile undifferentiated from placebo, with no serious adverse...
Canada's aviation firm CAE taps Northrop Grumman's Matthew Bromberg as CEO
Canada's aviation firm CAE taps Northrop Grumman's Matthew Bromberg as CEO
Jun 2, 2025
June 2 (Reuters) - Canadian aviation and defense technology company CAE, said on Monday it tapped Northrop Grumman's ( NOC ) Matthew Bromberg as its new chief executive officer. Bromberg, set to join on August 13, will be succeeding Marc Parent, who has been at the helm since 2009 and had announced his departure in November last year. Bromberg has...
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Copyright 2023-2026 - www.financetom.com All Rights Reserved